Daiwa Securities Group’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
RI
PCM
VCM
SPPAM
VPM
Daiwa Securities Group's CSTL Position: Q1 2026 in Review
Daiwa Securities Group sold out of Castle Biosciences (CSTL) in Q1 2026, closing a stake of 86 shares — an estimated $3K sold.
Daiwa Securities Group first reported a position in CSTL in Q4 2019 and held it in 25 quarters. The position peaked at $6K in Q3 2021. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.
- Daiwa Securities Group reported no remaining Castle Biosciences position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 86 Castle Biosciences shares in Q1 2026, an estimated $3K.
- Daiwa Securities Group first reported a position in Castle Biosciences in Q4 2019 and held it in 25 quarters.
- Daiwa Securities Group's Castle Biosciences position peaked at $6K in Q3 2021.
- 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.